The University of Chicago Header Logo

Connection

Ayodeji Adegunsoye to Pulmonary Fibrosis

Back to Details
This is a "connection" page, showing publications Ayodeji Adegunsoye has written about Pulmonary Fibrosis.
Ayodeji Adegunsoye
Connection Strength
5.963
Pulmonary Fibrosis
  1. Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. Nat Commun. 2023 03 17; 14(1):1489.
    View in: PubMed
    Score: 0.714
  2. Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US Adults. JAMA Netw Open. 2023 03 01; 6(3):e232427.
    View in: PubMed
    Score: 0.711
  3. Racial Disparities in Pulmonary Fibrosis and the Impact on the Black Population. Arch Bronconeumol. 2022 08; 58(8):590-592.
    View in: PubMed
    Score: 0.645
  4. Anticoagulation and Pulmonary Fibrosis: Friends, Foes, or Functional Allies? Chest. 2021 04; 159(4):1321-1323.
    View in: PubMed
    Score: 0.624
  5. MUC5B promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosis. Thorax. 2019 12; 74(12):1111-1112.
    View in: PubMed
    Score: 0.565
  6. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
    View in: PubMed
    Score: 0.545
  7. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm. 2015; 2015:510105.
    View in: PubMed
    Score: 0.411
  8. Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study. Respir Res. 2024 Dec 31; 25(1):448.
    View in: PubMed
    Score: 0.202
  9. Quantitative CT Scan Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease. Chest. 2025 May; 167(5):1428-1439.
    View in: PubMed
    Score: 0.200
  10. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):401-423.
    View in: PubMed
    Score: 0.197
  11. Use of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis. Ann Am Thorac Soc. 2024 Aug; 21(8):1156-1165.
    View in: PubMed
    Score: 0.196
  12. Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2024 Jan; 63(1).
    View in: PubMed
    Score: 0.189
  13. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
    View in: PubMed
    Score: 0.187
  14. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021 10 16; 398(10309):1450-1460.
    View in: PubMed
    Score: 0.161
  15. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Chest. 2019 05; 155(5):1026-1040.
    View in: PubMed
    Score: 0.134
  16. Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
    View in: PubMed
    Score: 0.122
  17. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
    View in: PubMed
    Score: 0.110
  18. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):392-400.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.